MedTrace Logo

Fish Collagen Peptide Food Supplement on Weight and Body Composition

NCT03872297 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2022-12-07

No results posted yet for this study

Summary

Fish collagen hydrolysates or peptides orally administered have been investigated in recent clinical trials in human health. These peptides have been evaluated in various biological and medical fields including skin aging, osteoarticular apparatus, muscle and more recently in energy metabolism in both animals and humans.

However, very few studies investigated the effect of fish collagen peptides on weight, body composition or glycemic response. Recently, it has been shown that the consumption of fish collagen peptides (Naticol®) limits weight gain and increase in fat mass in a mouse model made obese by a hyperlipidic diet. Since these results have never been observed in humans, this pilot study proposes to answer this question.

Conditions

Interventions

DIETARY_SUPPLEMENT

Placebo supplement

Consumption of a non active food complement during 3 months. Tests performed : * 2 blood tests : * 2 body composition analysis via Dual-energy X-ray absorptiometry (DXA) * 2 stool collections The first one of these analysis was performed at the beginning, second at the end of the study.

DIETARY_SUPPLEMENT

Naticol supplement

Consumption of the active food complement during 3 months containing Naticol. Tests performed : * 2 blood tests : * 2 body composition analysis via Dual-energy X-ray absorptiometry (DXA) * 2 stool collections The first one of these analysis was performed at the beginning, second at the end of the study.

Sponsors & Collaborators

  • Institut Pasteur de Lille

    lead OTHER

Principal Investigators

  • Jean-Michel LECERF, MD · Institut Pasteur de Lille - NutrInvest

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-01-14
Primary Completion
2019-06-30
Completion
2019-07-30

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03872297 on ClinicalTrials.gov